Neumora Therapeutics NMRA
NASDAQ NMRA
$0.68 -0.01 (-2.05%)
At close: Sep 29, 2026 · 4:00 PM EDT

Neumora Therapeutics (NMRA) Tax Provisions (2024 - 2026)

Updated

Neumora Therapeutics (NMRA) posted Tax Provisions of $30,000 for Q1 2026, down 71.4% from $105,000 a year earlier.

Analysis

Neumora Therapeutics (NMRA) Tax Provisions (2024 - 2026) Analysis & Trends

For FY2025, Neumora Therapeutics' Tax Provisions came in at $130,000, down 27.0% from FY2024.

  • In prior years, Neumora Therapeutics' Tax Provisions was $178,000 in FY2024 (-33.6%) and $268,000 in FY2023.
  • Quarterly Tax Provisions has run from a low of $25,000 in Q2 2025 to a high of $125,000 in Q2 2024 over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 1.21 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 662.00 Mn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 654.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -1.01 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -291.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 393.00 Mn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 242.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -407.00 Mn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 292.00 Mn
10 Neumora Therapeutics 129.65 Mn 129.65 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 30,000.00
Jun 30, 2025 25,000.00
Mar 31, 2025 105,000.00
Sep 30, 2024 53,000.00
Jun 30, 2024 125,000.00
API Access

Neumora Therapeutics Tax Provisions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=tax-provisions&ticker=NMRA&period=max&api_key=YOUR_API_KEY